Stock Splits
By The Online Investor Staff, updated Thu., Sep. 23, 1:27 AM
| This Slide: #3 of 25 |
Slide #3. AzurRx BioPharma, Inc. (NASDAQ:AZRX) — 1 for 10 Reverse Split
Announced:
9/10/2021
Stock Split:
1 for 10
Record Date:
9/10/2021
Pay Date:
9/13/2021
AZRX Optionable?:
No
AzurRx BioPharma is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Co. is focused on developing its drug product candidate, MS1819, a yeast derived recombinant lipase for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. Co.'s b-lactamase program focuses on products with an enzymatic combination of bacterial origin for the prevention of hospital-acquired infections and antibiotic-associated diarrhea by resistant bacterial strains induced by parenteral administration of several antibiotic classes. Co.'s compounds in pre-clinical development include: AZX1101 and AZX1103. 
AZRX Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the AZRX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.50 out of 4) 54th percentile
(ranked higher than approx. 54% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
